Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-17T21:29:37.801Z Has data issue: false hasContentIssue false
  • English
  • Français

Clinical Significance of Neutropenia in Patients With Human Immunodeficiency Virus Infection

Published online by Cambridge University Press:  21 June 2016

Bruce F. Farber ,
Martin Lesser ,
Mark H. Kaplan ,
Jeanine Woltmann ,
Barbara Napolitano  and
Donna Armellino
Bruce F. Farber*
Affiliation:
Departments of Medicine and Biostatistics, North Shore University Hospital, Manhasset, New York Cornell University Medical College, New York, New York
Martin Lesser
Affiliation:
Departments of Medicine and Biostatistics, North Shore University Hospital, Manhasset, New York Cornell University Medical College, New York, New York
Mark H. Kaplan
Affiliation:
Departments of Medicine and Biostatistics, North Shore University Hospital, Manhasset, New York Cornell University Medical College, New York, New York
Jeanine Woltmann
Affiliation:
Departments of Medicine and Biostatistics, North Shore University Hospital, Manhasset, New York
Barbara Napolitano
Affiliation:
Departments of Medicine and Biostatistics, North Shore University Hospital, Manhasset, New York
Donna Armellino
Affiliation:
Departments of Medicine and Biostatistics, North Shore University Hospital, Manhasset, New York
*
Division of Infectious Disease and Immunology, North Shore University Hospital, 300 Community Drive, Manhasset, New York 11030
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To determine the incidence of infection in human immunodeficiency virus (HIV)-infected patients during periods of neutropenia and non-neutropenia. To compare the infection rates in patients with HIV disease to those in a group hospitalized with neutropenia and hematologic malignancy.

Design:

Prospective observational study conducted between December 1985 and December 1987 at a university teaching hospital. Thirty patients with documented acquired immunodeficiency syndrome (AIDS) and absolute T-helper cells <200 mm/mm3. All patients had a period of non-neutropenia following a neutropenic period (neutrophils <1000 cells/mm3).

Results:

The rate of first infection during neutropenic and non-neutropenic periods for opportunistic infection and nonopportunistic infections were compared. There were no differences between infection rates for the two time periods for both types of infections. A subgroup of patient care days in which non-neutropenic days followed neutropenic days also was studied to eliminate selection bias. In this group, a comparison of infection rates also revealed no difference between neutropenic and non-neutropenic periods. An alternate analysis of the time until first infection during periods of neutropenia or non- neutropenia was done using the Kaplan-Meier product limit method. There was a longer infection-free period for the neutropenic group for opportunistic infections, but it was not statistically significant (p<.1). In addition, we compared HIV-infected patients with a group of 37 patients with neutropenia from hematologic malignancy. There was a significantly higher rate of all infections, particularly bacteremias (p<.001), in the group of patients with hematologic malignancies when compared with all subsets of patients with HIV disease.

Conclusion:

We conclude that patientswith HIV disease and modest neutropenia do not have an increased risk of bacterial infection. The incidence of all infections is significantly greater in patients with neutropenia secondary to hematologic malignancy, (Infect Control Hosp Epidemiol. 1991;12:429-434.)

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 12 , Issue 7 , July 1991 , pp. 429 - 434
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1991

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Zon, LI, Arkin, C, Groopman, JE. Haematologic manifestations of the human immune deficiency virus (HIV). Br J Haematol. 1987;66:251–256.10.1111/j.1365-2141.1987.tb01307.xGoogle Scholar
2. Murphy, ME Metcalfe, P, Waters, AH, et al. Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection. Br J Haematol. 1987;66:337–340.10.1111/j.1365-2141.1987.tb06920.xGoogle Scholar
3. Castella, A, Cloxson, TS, Mildvan, D, et al. The bone marrow in AIDS. Am J Clin Pathol. 1984;84:425–432.10.1093/ajcp/84.4.425CrossRefGoogle Scholar
4. Richman, DD, Fischl, MA. Grieco, MH, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med. 1987;517:192–196.10.1056/NEJM198707233170402Google Scholar
5. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR. 1987;36:15.Google Scholar
6. Kleinbaum, DG, Kupper, LL, Morganstern, H. Epidemiologic Research. Belmont, Calif: Lifetime Learning Publications; 1982.Google Scholar
7. Mantel, N, Ciminera, JL. Use of log rank scores in the analysis of litter-matched data on time to tumor appearance. Cancer Res. 1979;39:4308–4315.Google Scholar
8. Peto, R, Peto, J. Asymptomatically efficient rank invariant test procedures. Journal of the Royal Statistics Society. 1972;135:185–206.10.2307/2344317Google Scholar
9. Rubin, R, Young, L, eds. Clinical Approach to Infections in the Compromised Host. New York, NY: Plenum Medical; 1988.Google Scholar
10. Whimbey, E, Gold, JWM, Polsky, B, et al. Bacteremia and fungemia in patients with the acquired immune deficiency syndrome. Ann Intern Med. 1986;104:511–514.10.7326/0003-4819-104-4-511Google Scholar
11. Simberkoff, MS, El Sadr, W, Schiffman, G, Rahal, JJ Jr. Streptococcus pneumoniae infections and bacteremia in patients with acquired immune deficiency syndrome with report of a pneumococcal failure. Am Rev Respir Dis. 1984;130:1174–1176.Google Scholar
12. Glatt, AE, Chirquin, K, Landesman, SA. Treatment of infections associated with human immunodeficiency virus. N Engl J Med. 1988;318:1439–1448.10.1056/NEJM198806023182206CrossRefGoogle ScholarPubMed